₹170
(Inclusive of all Taxes)
₹25.5 Cashback (15%)
Prescription drugWhats That
Secure Payment
India's Most Trusted Pharmacy
Genuine Products
Also Explore
OUTPUT:```கலவை :
GATIFLOXACIN-0.5% W/V
உற்பத்தியாளர்/சந்தைப்படுத்துபவர் :
Allergan Healthcare India Pvt Ltd
பயன்படுத்தும் வகை :
கண் மருத்துவம்
திரும்பப் பெறும் கொள்கை :
திரும்பப் பெற முடியாது
முடிவடையும் அல்லது அதற்குப் பிறகு :
Jan-27
Drug-Drug Interactions
GatifloxacinTolbutamide
Critical
Critical
Drug-Drug Interactions
Login/Sign Up
GatifloxacinTolbutamide
Critical
How does the drug interact with Orbigat-Hs 0.5%W/V Eye Drops 5ml:
Coadministration of Orbigat-Hs 0.5%W/V Eye Drops 5ml and Tolbutamide may sometimes affect blood glucose levels. Both high blood glucose and, less frequently, low blood glucose have been reported.
How to manage the interaction:
There may be a possibility of interaction between Orbigat-Hs 0.5%W/V Eye Drops 5ml and Tolbutamide, but it can be taken if prescribed by a doctor. Consult the prescriber if you experience symptoms such as nervousness, confusion, headache, dizziness, drowsiness, tremors, nausea, hunger, weakness, perspiration, palpitation, rapid heartbeat, increased urination, increased thirst, and increased hunger. Maintaining blood glucose levels is advised.
Coadministration of Orbigat-Hs 0.5%W/V Eye Drops 5ml and Tolbutamide may sometimes affect blood glucose levels. Both high blood glucose and, less frequently, low blood glucose have been reported.
How to manage the interaction:
There may be a possibility of interaction between Orbigat-Hs 0.5%W/V Eye Drops 5ml and Tolbutamide, but it can be taken if prescribed by a doctor. Consult the prescriber if you experience symptoms such as nervousness, confusion, headache, dizziness, drowsiness, tremors, nausea, hunger, weakness, perspiration, palpitation, rapid heartbeat, increased urination, increased thirst, and increased hunger. Maintaining blood glucose levels is advised.
Critical
How does the drug interact with Orbigat-Hs 0.5%W/V Eye Drops 5ml:
Taking Sotalol with Orbigat-Hs 0.5%W/V Eye Drops 5ml can increase the risk or severity of irregular heart rhythms. The risk increases in patients with a history of heart illness or electrolyte imbalance.
How to manage the interaction:
Taking Sotalol with Orbigat-Hs 0.5%W/V Eye Drops 5ml together can result in an interaction, it can be taken if a doctor has advised it. However, if you experience sudden dizziness, lightheadedness, fainting, shortness of breath, chest pain or tightness, rapid heartbeat, consult a doctor immediately. Do not discontinue any medications without consulting a doctor.
Taking Sotalol with Orbigat-Hs 0.5%W/V Eye Drops 5ml can increase the risk or severity of irregular heart rhythms. The risk increases in patients with a history of heart illness or electrolyte imbalance.
How to manage the interaction:
Taking Sotalol with Orbigat-Hs 0.5%W/V Eye Drops 5ml together can result in an interaction, it can be taken if a doctor has advised it. However, if you experience sudden dizziness, lightheadedness, fainting, shortness of breath, chest pain or tightness, rapid heartbeat, consult a doctor immediately. Do not discontinue any medications without consulting a doctor.
GatifloxacinRosiglitazone
Critical
How does the drug interact with Orbigat-Hs 0.5%W/V Eye Drops 5ml:
Coadministration of Orbigat-Hs 0.5%W/V Eye Drops 5ml with Rosiglitazone may sometimes affect blood glucose levels. Both low blood glucose and, less frequently, high blood glucose have been reported.
How to manage the interaction:
Although there is a possible interaction, Rosiglitazone can be taken with Orbigat-Hs 0.5%W/V Eye Drops 5ml if prescribed by the doctor. Consult the prescriber if you experience symptoms such as nervousness, confusion, headache, dizziness, drowsiness, tremor, nausea, hunger, weakness, perspiration, palpitation, rapid heartbeat, increased urination, increased thirst, and increased hunger. Maintaining blood glucose levels is advised.
Coadministration of Orbigat-Hs 0.5%W/V Eye Drops 5ml with Rosiglitazone may sometimes affect blood glucose levels. Both low blood glucose and, less frequently, high blood glucose have been reported.
How to manage the interaction:
Although there is a possible interaction, Rosiglitazone can be taken with Orbigat-Hs 0.5%W/V Eye Drops 5ml if prescribed by the doctor. Consult the prescriber if you experience symptoms such as nervousness, confusion, headache, dizziness, drowsiness, tremor, nausea, hunger, weakness, perspiration, palpitation, rapid heartbeat, increased urination, increased thirst, and increased hunger. Maintaining blood glucose levels is advised.
Critical
How does the drug interact with Orbigat-Hs 0.5%W/V Eye Drops 5ml:
Taking Orbigat-Hs 0.5%W/V Eye Drops 5ml with Cisapride can increase the risk or severity of irregular heart rhythms. The risk increases in patients with a history of heart illness or electrolyte imbalance.
How to manage the interaction:
Taking Orbigat-Hs 0.5%W/V Eye Drops 5ml with Cisapride together is not recommended as it can possibly result in an interaction, it can be taken if your doctor has advised it. However, if you experience sudden dizziness, lightheadedness, fainting, shortness of breath, chest pain or tightness, rapid heartbeat, or memory loss, contact your doctor immediately. Do not discontinue any medications without consulting a doctor.
Taking Orbigat-Hs 0.5%W/V Eye Drops 5ml with Cisapride can increase the risk or severity of irregular heart rhythms. The risk increases in patients with a history of heart illness or electrolyte imbalance.
How to manage the interaction:
Taking Orbigat-Hs 0.5%W/V Eye Drops 5ml with Cisapride together is not recommended as it can possibly result in an interaction, it can be taken if your doctor has advised it. However, if you experience sudden dizziness, lightheadedness, fainting, shortness of breath, chest pain or tightness, rapid heartbeat, or memory loss, contact your doctor immediately. Do not discontinue any medications without consulting a doctor.
Critical
How does the drug interact with Orbigat-Hs 0.5%W/V Eye Drops 5ml:
Co-administration of Pioglitazone with Orbigat-Hs 0.5%W/V Eye Drops 5ml may sometimes affect blood glucose levels. Both high blood glucose and, less frequently, low blood glucose have been reported.
How to manage the interaction:
Although there is a possible interaction, Pioglitazone can be taken with Orbigat-Hs 0.5%W/V Eye Drops 5ml if prescribed by the doctor. Consult the prescriber if you experience symptoms such as nervousness, confusion, headache, dizziness, drowsiness, tremors, nausea, hunger, weakness, excessive sweating, rapid heartbeat, increased urination, increased thirst, and increased hunger. Maintaining blood glucose levels is advised. Do not discontinue any medications without a doctor's advice.
Co-administration of Pioglitazone with Orbigat-Hs 0.5%W/V Eye Drops 5ml may sometimes affect blood glucose levels. Both high blood glucose and, less frequently, low blood glucose have been reported.
How to manage the interaction:
Although there is a possible interaction, Pioglitazone can be taken with Orbigat-Hs 0.5%W/V Eye Drops 5ml if prescribed by the doctor. Consult the prescriber if you experience symptoms such as nervousness, confusion, headache, dizziness, drowsiness, tremors, nausea, hunger, weakness, excessive sweating, rapid heartbeat, increased urination, increased thirst, and increased hunger. Maintaining blood glucose levels is advised. Do not discontinue any medications without a doctor's advice.
Critical
How does the drug interact with Orbigat-Hs 0.5%W/V Eye Drops 5ml:
Co-administration of Dapagliflozin with Orbigat-Hs 0.5%W/V Eye Drops 5ml may sometimes affect blood glucose levels. Both low blood glucose and, less frequently, high blood glucose have been reported.
How to manage the interaction:
Although there is a possible interaction, Orbigat-Hs 0.5%W/V Eye Drops 5ml can be taken with Dapagliflozin if prescribed by the doctor. Consult the prescriber if you experience symptoms such as nervousness, confusion, headache, dizziness, drowsiness, tremor, nausea, hunger, weakness, perspiration, palpitation, rapid heartbeat, increased urination, increased thirst, and increased hunger. Maintaining blood glucose levels is advised. Do not discontinue the medication without consulting a doctor.
Co-administration of Dapagliflozin with Orbigat-Hs 0.5%W/V Eye Drops 5ml may sometimes affect blood glucose levels. Both low blood glucose and, less frequently, high blood glucose have been reported.
How to manage the interaction:
Although there is a possible interaction, Orbigat-Hs 0.5%W/V Eye Drops 5ml can be taken with Dapagliflozin if prescribed by the doctor. Consult the prescriber if you experience symptoms such as nervousness, confusion, headache, dizziness, drowsiness, tremor, nausea, hunger, weakness, perspiration, palpitation, rapid heartbeat, increased urination, increased thirst, and increased hunger. Maintaining blood glucose levels is advised. Do not discontinue the medication without consulting a doctor.
GatifloxacinTolazamide
Critical
How does the drug interact with Orbigat-Hs 0.5%W/V Eye Drops 5ml:
coadministration of Orbigat-Hs 0.5%W/V Eye Drops 5ml with Tolazamide may sometimes affect blood glucose levels. Both low blood glucose and, less frequently, high blood glucose have been reported.
How to manage the interaction:
Co-administration of Orbigat-Hs 0.5%W/V Eye Drops 5ml with Tolazamide is not recommended as it can possibly result in an interaction, but it can be taken if your doctor has advised it. Consult the prescriber if you experience symptoms such as nervousness, confusion, headache, dizziness, drowsiness, tremor, nausea, hunger, weakness, perspiration, palpitation, rapid heartbeat, increased urination, increased thirst, and increased hunger. Maintaining blood glucose levels is advised.
coadministration of Orbigat-Hs 0.5%W/V Eye Drops 5ml with Tolazamide may sometimes affect blood glucose levels. Both low blood glucose and, less frequently, high blood glucose have been reported.
How to manage the interaction:
Co-administration of Orbigat-Hs 0.5%W/V Eye Drops 5ml with Tolazamide is not recommended as it can possibly result in an interaction, but it can be taken if your doctor has advised it. Consult the prescriber if you experience symptoms such as nervousness, confusion, headache, dizziness, drowsiness, tremor, nausea, hunger, weakness, perspiration, palpitation, rapid heartbeat, increased urination, increased thirst, and increased hunger. Maintaining blood glucose levels is advised.
GatifloxacinHalofantrine
Critical
How does the drug interact with Orbigat-Hs 0.5%W/V Eye Drops 5ml:
Taking Orbigat-Hs 0.5%W/V Eye Drops 5ml with Halofantrine can increase the risk or severity of irregular heart rhythms. The risk increases in patients with a history of heart illness or electrolyte imbalance.
How to manage the interaction:
Taking Orbigat-Hs 0.5%W/V Eye Drops 5ml with Halofantrine together can possibly result in an interaction, it can be taken if your doctor has advised it. However, if you experience sudden dizziness, lightheadedness, fainting, shortness of breath, chest pain or tightness, rapid heartbeat, or memory loss, contact your doctor immediately. Do not discontinue any medications without consulting a doctor.
Taking Orbigat-Hs 0.5%W/V Eye Drops 5ml with Halofantrine can increase the risk or severity of irregular heart rhythms. The risk increases in patients with a history of heart illness or electrolyte imbalance.
How to manage the interaction:
Taking Orbigat-Hs 0.5%W/V Eye Drops 5ml with Halofantrine together can possibly result in an interaction, it can be taken if your doctor has advised it. However, if you experience sudden dizziness, lightheadedness, fainting, shortness of breath, chest pain or tightness, rapid heartbeat, or memory loss, contact your doctor immediately. Do not discontinue any medications without consulting a doctor.
Critical
How does the drug interact with Orbigat-Hs 0.5%W/V Eye Drops 5ml:
Coadministration of Repaglinide with Orbigat-Hs 0.5%W/V Eye Drops 5ml may sometimes affect blood glucose levels. Both low blood glucose and, less frequently, high blood glucose have been reported.
How to manage the interaction:
Although there is a possible interaction, Repaglinide can be taken with Orbigat-Hs 0.5%W/V Eye Drops 5ml if prescribed by the doctor. However, consult the doctor if you experience unusual symptoms. Do not stop using any medications without first talking to your doctor.
Coadministration of Repaglinide with Orbigat-Hs 0.5%W/V Eye Drops 5ml may sometimes affect blood glucose levels. Both low blood glucose and, less frequently, high blood glucose have been reported.
How to manage the interaction:
Although there is a possible interaction, Repaglinide can be taken with Orbigat-Hs 0.5%W/V Eye Drops 5ml if prescribed by the doctor. However, consult the doctor if you experience unusual symptoms. Do not stop using any medications without first talking to your doctor.
Critical
How does the drug interact with Orbigat-Hs 0.5%W/V Eye Drops 5ml:
Coadministration of Empagliflozin with Orbigat-Hs 0.5%W/V Eye Drops 5ml may sometimes affect blood glucose levels. Both high blood glucose and, less frequently, low blood glucose have been reported.
How to manage the interaction:
It is not recommended to take Empagliflozin with Gatifloxacinas it can result in an interaction, but it can be taken if advised by the doctor. Consult the prescriber if you experience symptoms such as nervousness, confusion, headache, dizziness, drowsiness, tremors, nausea, hunger, weakness, perspiration, palpitation, rapid heartbeat, increased urination, increased thirst, and increased hunger. Maintaining blood glucose levels is advised. Do not discontinue any medication without consulting a doctor.
Coadministration of Empagliflozin with Orbigat-Hs 0.5%W/V Eye Drops 5ml may sometimes affect blood glucose levels. Both high blood glucose and, less frequently, low blood glucose have been reported.
How to manage the interaction:
It is not recommended to take Empagliflozin with Gatifloxacinas it can result in an interaction, but it can be taken if advised by the doctor. Consult the prescriber if you experience symptoms such as nervousness, confusion, headache, dizziness, drowsiness, tremors, nausea, hunger, weakness, perspiration, palpitation, rapid heartbeat, increased urination, increased thirst, and increased hunger. Maintaining blood glucose levels is advised. Do not discontinue any medication without consulting a doctor.
Drug-Food Interactions
No Drug - Food interactions found in our database. Some may be unknown. Consult your doctor for what to avoid during medication.
Drug-Food Interactions
Login/Sign Up
Orbigat-Hs 0.5%W/V Eye Drops 5ml Substitute
Product Substitutes
மது
எச்சரிக்கை
Orbigat-Hs 0.5%W/V Eye Drops 5ml உடன் மதுவின் தொடர்பு தெரியவில்லை. Orbigat-Hs 0.5%W/V Eye Drops 5ml சிகிச்சையின் போது மது அருந்துவதற்கு முன் உங்கள் மருத்துவரை அணுகவும்.
கர்ப்பம்
எச்சரிக்கை
கர்ப்பிணிப் பெண்களை Orbigat-Hs 0.5%W/V Eye Drops 5ml பாதிக்குமா என்பது தெரியவில்லை. எனவே, நீங்கள் கர்ப்பமாக இருந்தால் Orbigat-Hs 0.5%W/V Eye Drops 5ml பயன்படுத்துவதற்கு முன் ஒரு மருத்துவரை அணுகவும்.
தாய்ப்பால்
எச்சரிக்கை
Orbigat-Hs 0.5%W/V Eye Drops 5ml தாய்ப்பாலில் கலக்கிறதா என்பது தெரியவில்லை. நீங்கள் தாய்ப்பால் கொடுப்பவராக இருந்தால் Orbigat-Hs 0.5%W/V Eye Drops 5ml எடுத்துக்கொள்வதற்கு முன் உங்கள் மருத்துவரை அணுகவும்.
ஓட்டுதல்
எச்சரிக்கை
Orbigat-Hs 0.5%W/V Eye Drops 5ml பொதுவாக தற்காலிகமாக மங்கலான பார்வையை ஏற்படுத்துகிறது. எனவே, உங்கள் பார்வை தெளிவாகும் வரை வாகனம் ஓட்டுதல் அல்லது இயந்திரங்களை இயக்குவதைத் தவிர்க்கவும்.
கல்லிகை
எச்சரிக்கை
உங்களுக்கு ஏதேனும் கல்லீரல் பிரச்சினைகள் இருந்தால் உங்கள் மருத்துவரை அணுகவும்.
சிறுநீரகம்
எச்சரிக்கை
உங்களுக்கு ஏதேனும் சிறுநீரகப் பிரச்சினைகள் இருந்தால் உங்கள் மருத்துவரை அணுகவும்.
குழந்தைகள்
எச்சரிக்கை
1 வயதுக்குட்பட்ட குழந்தைகளுக்கு Orbigat-Hs 0.5%W/V Eye Drops 5ml பரிந்துரைக்கப்படவில்லை. இருப்பினும், குழந்தைகளுக்கு Orbigat-Hs 0.5%W/V Eye Drops 5ml கொடுப்பதற்கு முன் ஒரு மருத்துவரை அணுகவும்.
Have a query?
Disclaimer
While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.
Author Details
